SILO 8-K 2026-10-02

Silo Pharma, Inc. (SILO) 8-K dated 2026-10-02 — accession 0001213900-26-106435. This URL is the filing, not the SILO hub.

Silo Pharma, Inc. (SILO) is a biotechnology company listed on US.

Silo Pharma, Inc. filed a 8-K on 2026-10-02. Accession 0001213900-26-106435.

Cached items: 1.01, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SILO revenue for 2025-12-31 was $72.1K. Net income was -$4.2M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. SILO currently screens at market cap $4.4M.

Not investment advice. The SILO SEC hub lists recent forms. The stock page is the research view.